Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoids-Reference-Cited by-同舟云学术

Androgen receptor mutations modulate activation by 11-oxygenated androgens and glucocorticoids

Published:2022-01-19 Issue: Volume: Page:
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Snaterse Gido,Mies Rosinda,van Weerden Wytske M.^ORCID,French Pim J.,Jonker Johan W.,Houtsmuller Adriaan B.,van Royen Martin E.,Visser Jenny A.^ORCID,Hofland Johannes^ORCID

Funder

Daniel den Hoed Foundation

AMH Assay royalties to the Visser Lab

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

https://www.nature.com/articles/s41391-022-00491-z.pdf

Reference47 articles.

1. Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004;10:33–9.

2. Mohler JL, Gregory CW, Ford OH 3rd, Kim D, Weaver CM, Petrusz P, et al. The androgen axis in recurrent prostate cancer. Clin Cancer Res. 2004;10:440–8.

3. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res. 2006;66:2815–25.

4. Beltran H, Yelensky R, Frampton GM, Park K, Downing SR, MacDonald TY, et al. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. Eur Urol. 2013;63:920–6.

5. Jernberg E, Bergh A, Wikstrom P. Clinical relevance of androgen receptor alterations in prostate cancer. Endocr Connect. 2017;6:R146–R61.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A combined in vitro-in silico method for assessing the androgenic activities of bisphenol A and its analogues;Toxicology in Vitro;2024-06

2. Androgen Signaling in Prostate Cancer: When a Friend Turns Foe;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-05-31

3. Role of extracellular vesicles in castration-resistant prostate cancer;Critical Reviews in Oncology/Hematology;2024-05

4. Prevalence and Spectrum of AR Ligand-Binding Domain Mutations Detected in Circulating-Tumor DNA Across Disease States in Men With Metastatic Castration-Resistant Prostate Cancer;JCO Precision Oncology;2024-05

5. Inhibition of the glucocorticoid‐activating enzyme 11β‐hydroxysteroid dehydrogenase type 1 drives concurrent 11‐oxygenated androgen excess;The FASEB Journal;2024-03-29